US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NanoViricides

1.57

+0.10006.80%

Pre-market: 1.55-0.0200-1.27%08:47 EDT

Volume:324.49K

Turnover:504.70K

Market Cap:24.56M

PE:-2.28

High:1.59

Open:1.56

Low:1.51

Close:1.47

Loading ...

Overview Company News Filings

NanoViricides Inc. Announces Imminent Animal Study for Promising Measles Drug Candidate NV-387

NanoViricides Inc. Announces Phase II Clinical Trial for Broad-Spectrum Antiviral NV-387 to Combat MPox and Measles Outbreaks

Nanoviricides Q3 GAAP EPS $(0.14) Up From $(0.16) YoY

NanoViricides, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference, May 14th, NYC

Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It

ACCESS Newswire

NanoViricides Inc: Begun Evaluation of Its Clinical Drug Nv-387 for Treatment of Measles Virus

THOMSON REUTERS

Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak

ACCESS Newswire

NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company

ACCESS Newswire

Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan

ACCESS Newswire

NanoViricides reports Q2 EPS (14c) vs. (18c) last year

NanoViricides, Inc. Has Filed its Quarterly Report

ACCESS Newswire

NanoViricides: Fiscal Q2 Earnings Snapshot

Associated Press Finance

Is NanoViricides Inc. (NNVC) the Best Nanotech Penny Stock to Invest In?

NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape

ACCESS Newswire

NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025

ACCESS Newswire

NanoViricides Inc: Engages Cro for Phase Ii Clinical Trial

THOMSON REUTERS

NanoViricides Engages CRO for Phase II Clinical Trial

ACCESS Newswire

NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025

Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals

NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NNVC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NNVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NNVC\",,,,,undefined,":{"symbol":"NNVC","market":"US","secType":"STK","nameCN":"NanoViricides","latestPrice":1.57,"timestamp":1749067200000,"preClose":1.47,"halted":0,"volume":324485,"hourTrading":{"tag":"盘前","latestPrice":1.55,"preClose":1.57,"latestTime":"08:47 EDT","volume":2121,"amount":3254.0950427999996,"timestamp":1749127631622},"delay":0,"floatShares":15074310,"shares":15641611,"eps":-0.688325,"marketStatus":"Pre-Mkt","change":0.1,"latestTime":"06-05 08:47:54 EDT","open":1.56,"high":1.59,"low":1.5101,"amount":504695.727081,"amplitude":0.054354,"askPrice":1.63,"askSize":300,"bidPrice":1.39,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.688325,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749130200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1380081600000,"exchange":"AMEX","adjPreClose":1.57,"preHourTrading":{"tag":"盘前","latestPrice":1.55,"preClose":1.57,"latestTime":"08:47 EDT","volume":2121,"amount":3254.0950427999996,"timestamp":1749127631622},"postHourTrading":{"tag":"盘后","latestPrice":1.58,"preClose":1.57,"latestTime":"19:34 EDT","volume":2846,"amount":4368.839,"timestamp":1749080090343},"volumeRatio":1.8399430688652756,"impliedVol":0.5404,"impliedVolPercentile":0.4337},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NNVC\",,,,,undefined,":{"symbol":"NNVC","floatShares":15074310,"roa":"-57.38%","roe":"-99.84%","lyrEps":-0.698686,"volumeRatio":1.8399430688652756,"shares":15641611,"dividePrice":0,"high":1.59,"amplitude":0.054354,"preClose":1.47,"low":1.5101,"week52Low":0.94,"pbRate":"2.78","week52High":3.59,"institutionHeld":0,"latestPrice":1.57,"committee":-0.5,"eps":-0.688325,"divideRate":0,"volume":324485,"delay":0,"ttmEps":-0.688325,"open":1.56,"prevYearClose":1.43,"prevWeekClose":1.52,"prevMonthClose":1.52,"prevQuarterClose":1.17,"fiveDayClose":1.66,"twentyDayClose":1.2611,"sixtyDayClose":1.16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NNVC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540050346","title":"NanoViricides Inc. Announces Imminent Animal Study for Promising Measles Drug Candidate NV-387","url":"https://stock-news.laohu8.com/highlight/detail?id=2540050346","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540050346?lang=en_us&edition=fundamental","pubTime":"2025-06-04 18:55","pubTimestamp":1749034520,"startTime":"0","endTime":"0","summary":"NanoViricides Inc., a clinical-stage company specializing in broad-spectrum antivirals, has announced the imminent commencement of an animal study for its Measles drug development program. The study will evaluate drug candidates in a lethal animal infection model, using specially modified mice that express the human CD150/SLAM protein, necessary for Measles virus entry into cells. The company is advancing its drug NV-387, which previously demonstrated efficacy against RSV in animals and may show similar effectiveness against Measles. NV-387 acts by mimicking cell features to bind and destroy viruses. The study aims to assess NV-387's potential for treating Measles, addressing a growing need as current Measles genotypes drift from existing vaccine strains. There is currently no approved drug for Measles, with Vitamin A and ribavirin being used in specific cases. Results from this study will inform the potential human application of NV-387.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nNDL47VQjN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","NNVC","BK4139"],"gpt_icon":0},{"id":"2535239833","title":"NanoViricides Inc. Announces Phase II Clinical Trial for Broad-Spectrum Antiviral NV-387 to Combat MPox and Measles Outbreaks","url":"https://stock-news.laohu8.com/highlight/detail?id=2535239833","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535239833?lang=en_us&edition=fundamental","pubTime":"2025-05-16 18:31","pubTimestamp":1747391489,"startTime":"0","endTime":"0","summary":"NanoViricides Inc. Announces Phase II Clinical Trial for Broad-Spectrum Antiviral NV-387 to Combat MPox and Measles Outbreaks. NanoViricides Inc. has announced the advancement of its broad-spectrum antiviral drug candidate, NV-387, into Phase II clinical trials. The trials aim to evaluate the drug's effectiveness in treating MPox infections, a pressing medical need given the ongoing pandemic in Africa and spillover cases globally. NV-387 has previously demonstrated promising results in animal models against various viruses, including RSV, Influenza, and Poxviruses. Additionally, the company is preparing for Phase II trials targeting Viral Acute and Severe Acute Respiratory Infections. NanoViricides is also exploring NV-387's potential against Measles and Bird Flu. The company reported financial constraints but plans to secure funding through equity markets and partnerships to continue its development objectives.Disclaimer: This news brief was created by Public Technologies  using gener","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL4Rpq2n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","NNVC"],"gpt_icon":0},{"id":"2535122806","title":"Nanoviricides Q3 GAAP EPS $(0.14) Up From $(0.16) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2535122806","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535122806?lang=en_us&edition=fundamental","pubTime":"2025-05-16 05:44","pubTimestamp":1747345464,"startTime":"0","endTime":"0","summary":"Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.14) per share. This is a 12.5 percent increase over losses of $(0.16) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45456458/nanoviricides-q3-gaap-eps-0-14-up-from-0-16-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NNVC"],"gpt_icon":0},{"id":"2533586096","title":"NanoViricides, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference, May 14th, NYC","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586096","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586096?lang=en_us&edition=fundamental","pubTime":"2025-05-05 18:30","pubTimestamp":1746441000,"startTime":"0","endTime":"0","summary":"Shelton, Connecticut-- - NanoViricides, Inc. , , a leading clinical stage global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City.Anil R. Diwan, President & Executive Chairman, will be hosting one-on-one meetings on May 14th from 9:00 A.M. to 3:00 P.M. .To register for one-on-one meetings with management at The Plaza Hotel in New York City, interested parties should contact John Perez at jperez@dboralcapital.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nanoviricides-inc-announces-participation-d-103000436.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-inc-announces-participation-d-103000436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4590","BK4581","BK4160","BK4561","BK4233","ET","BK4588","BK4568","NNVC","BK4585","NYC","BK4144","BK4139"],"gpt_icon":0},{"id":"2531816517","title":"Measles is Likely to Become Endemic - NanoViricides Is Testing a Drug to Combat It","url":"https://stock-news.laohu8.com/highlight/detail?id=2531816517","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531816517?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:30","pubTimestamp":1745922600,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / April 29, 2025 / NanoViricides, Inc., a publicly traded company  , and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, provides further details on its Measles drug development program herewith.To date, only effective drugs have brought or maintained endemic or circulating viruses under control. There are no vaccines for herpes viruses, HIV or hepatitis C virus. Yet, successful drugs have helped patients to be cured , or recover from episodes , or at least maintain healthy lifespan  without any vaccines.Although there is a successful vaccine for measles, there are several reasons why vaccination rates are declining. First and foremost is the fear of side effects. Even if the side effects are uncommon, what parents would want their child to become part of the unfortunate statistic?Secondly, there is a lack of public trust fomented by the aggressive and dogmat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/measles-likely-become-endemic-nanoviricides-103000449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2527134008","title":"NanoViricides Inc: Begun Evaluation of Its Clinical Drug Nv-387 for Treatment of Measles Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2527134008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527134008?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:32","pubTimestamp":1744626768,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QQ04Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2527430155","title":"Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak","url":"https://stock-news.laohu8.com/highlight/detail?id=2527430155","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527430155?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:30","pubTimestamp":1744626600,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / April 14, 2025 / NanoViricides, Inc., a publicly traded company  , and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that it has begun evaluation of its clinical drug NV-387 for the treatment of the Measles virus.NanoViricides is open to enabling use of NV-387 to combat Measles virus infection in hospitalized patients and welcomes inquiries that are consistent with current FDA regulatory requirements under \"Emergency Expanded Access for an Individual Patient\" and under \"Expanded Access for an Individual Patient\".The Company has planned additional laboratory studies to evaluate the effectiveness of NV-387 against Measles virus infection in cell culture and animal models to support a future IND application, although we believe the results of these studies would not be required for use of NV-387 under FDA regulations pertaining to \"Emergency ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/measles-outbreak-expands-begging-drug-103000782.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC","BK4139","BK4568"],"gpt_icon":0},{"id":"2518147107","title":"NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2518147107","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518147107?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:30","pubTimestamp":1741689000,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. , a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot escape, declared today that its business is not affected by the tariff policies of the US government or corresponding retaliatory policies of other governments, nor is it affected by the spending cuts being implemented by the current White House administration.Therefore, the Company believes that smart financial strategists would view the longer term strong prospects of the Company  as supporting the case of NNVC as an effective hedge against the current general stock market turmoil.\"We believe that the policies of the current Secretary of HHS, Mr. Robert F. Kennedy, would lead to focusing more strongly on development of broad-spectrum antiviral treatments such as our clinical-stage as well as earlier-stage antiviral pipeline drug products rather than the previous vaccine-focused strategy,\" said Anil R. Diw","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-not-affected-tariffs-other-103000613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC","BK4568","BK4139"],"gpt_icon":0},{"id":"2516271126","title":"Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2516271126","media":"ACCESS Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516271126?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:30","pubTimestamp":1741087800,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / March 4, 2025 / The HHS Department Secretary Robert F. Kennedy Jr. wrote an Opinion piece in the FoxNews entitled \"Measles outbreak is call to action for all of us\". He identifies an important issue that, \"…there is no approved antiviral for those who may be infected…\"We applaud Secretary Kennedy for recognizing the urgency of the situation and taking all possible steps including promoting vaccination in response to this outbreak, while clearly recognizing the deficiency in the response to be the lack of an effective treatment for measles viral disease,\" said Anil R. Diwan, PhD., President of NanoViricides, Inc.We note that the current efforts at containment with case-tracking, contact-tracing and isolation, face daunting challenges to be effective because measles is far more contagious than SARS-CoV-2 that caused the global COVID pandemic. In fact, measles is the most contagious disease known to humans. Also, a person may be contagious several days befo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/measles-outbreak-nv-387-promises-113000537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","BK4139","HHS","BK4009","NNVC"],"gpt_icon":0},{"id":"2512101445","title":"NanoViricides reports Q2 EPS (14c) vs. (18c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2512101445","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512101445?lang=en_us&edition=fundamental","pubTime":"2025-02-19 20:50","pubTimestamp":1739969423,"startTime":"0","endTime":"0","summary":"The company said, “We reported that, as of December 31, 2024, we had cash and cash equivalent current assets balance of approximately $3.96 Million...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nanoviricides-reports-q2-eps-14c-vs-18c-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nanoviricides-reports-q2-eps-14c-vs-18c-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NNVC"],"gpt_icon":0},{"id":"2512810520","title":"NanoViricides, Inc. Has Filed its Quarterly Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2512810520","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512810520?lang=en_us&edition=fundamental","pubTime":"2025-02-19 19:30","pubTimestamp":1739964600,"startTime":"0","endTime":"0","summary":"Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu. We reported that, as of December 31, 2024, we had cash and cash equivalent current assets balance of approximately $3.96 Million. In addition, we reported approximately $7.17 Million in Net Property and Equipment (P&E) assets . The strong P&E assets comprise our cGMP-capable manufacturing and R&D facility in Shelton, CT. The total current liabilities were approximately $1.18 Million.The net cash utilized during the six months ended December 31, 2024 was approximately $4.79 million. This included certain non-recurring expenditures including R&D expenditures in preparation for a Phase II clinical trial application. We raised approximately $4 million net of commission and certain expenses in an At-the-Market offering  during the six months ended December 31, 2024.There is no drug available for the treatment of MPox infection. The MPox Clade 1/1b has a substantially g","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-inc-filed-quarterly-report-113000804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","NNVC","BK4139"],"gpt_icon":0},{"id":"2511610418","title":"NanoViricides: Fiscal Q2 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2511610418","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511610418?lang=en_us&edition=fundamental","pubTime":"2025-02-15 05:37","pubTimestamp":1739569040,"startTime":"0","endTime":"0","summary":"SHELTON, Conn.  — SHELTON, Conn.  — NanoViricides Inc.  on Friday reported a loss of $2 million in its fiscal second quarter.On a per-share basis, the Shelton, Connecticut-based company said it had a loss of 14 cents.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-fiscal-q2-earnings-snapshot-213720728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC"],"gpt_icon":0},{"id":"2511645049","title":"Is NanoViricides Inc. (NNVC) the Best Nanotech Penny Stock to Invest In?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511645049","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511645049?lang=en_us&edition=fundamental","pubTime":"2025-02-15 00:29","pubTimestamp":1739550576,"startTime":"0","endTime":"0","summary":"We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at where NanoViricides Inc.  stands against other best nanotech penny stocks to invest in.Nanotech involves working with tiny particles which are about the size of molecules. This field is being used to improve products in many different industries, like electronics, medicine, and energy. By manipulating matter at this tiny scale, materials and devices with special properties can be made. The global nanotech market was valued at $3.69 billion in 2022 and is projected to grow at a 33.1% CAGR from 2023 to 2030, as reported by Grand View Research. This is driven by the increased use in medical diagnostics and imaging, technological advancements, substantial R&D funding, and the creation of advanced materials for healthcare, electronics, aerospace, textiles, transportation, manufacturing, and agriculture.While the nanotech industry as a whole holds promise, it is still in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-inc-nnvc-best-nanotech-162936380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","NNVC","BK4568"],"gpt_icon":0},{"id":"2510097802","title":"NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape","url":"https://stock-news.laohu8.com/highlight/detail?id=2510097802","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510097802?lang=en_us&edition=fundamental","pubTime":"2025-02-11 19:30","pubTimestamp":1739273400,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc.   declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu virus H5N1 likely cannot escape despite its ability to mutate rapidly with genomic changes.An \"opinion and analysis\" article published in Scientific American on February 7th correctly recognizes that the H5N1 \"virus is versatile…This article's titular declaration that the \"US is not ready for bird flu in humans\" is myopic.We beg to differ from this opinion, and hereby declare that our broad-spectrum antiviral drug NV-387 that H5N1 virus will not be able to escape even as it changes in the field, is ready to fight the battle and save lives, should a human H5N1 pandemic occur.The bird-flu virus and its variants are highly unlikely to escape the broad spectrum, host-mimetic, antiviral drug NV-387, because all of these variants continue to land on the same host-side feature that ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-drug-fight-bird-flu-113000223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NNVC","BK4568","BK4139"],"gpt_icon":0},{"id":"2507246684","title":"NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2507246684","media":"ACCESS Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507246684?lang=en_us&edition=fundamental","pubTime":"2025-01-29 19:30","pubTimestamp":1738150200,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc.  , a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it is presenting today, January 29, at 11am at the MicroCap Conference 2025 in Atlantic City, NJ.NanoViricides Presentation at the MicroCap Conference, Atlantic City. NanoViricides is rapidly moving towards Phase II Safety, Tolerability and Efficacy Evaluation of its Lead Drug candidate, NV-387, for the Treatment of MPOX disease. The Company has announced that it has engaged a CRO for conducting the Phase II clinical trials in the African Region.The Phase II-ready drug NV-387 has demonstrated extremely broad antiviral spectrum of activity in animal models, which could prove to be as revolutionary for viral infections as penicillin was for bacterial infections. This broad spectrum is because NV-387 is designed to mimic a host-side feature that is used by over 90-95% of human pathogenic virus","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-present-microcap-conference-wednesday-113000322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","NNVC","BK4139"],"gpt_icon":0},{"id":"2506373936","title":"NanoViricides Inc: Engages Cro for Phase Ii Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2506373936","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506373936?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:34","pubTimestamp":1737977649,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3OL08B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NNVC","BK4568","BK4139"],"gpt_icon":0},{"id":"2506384376","title":"NanoViricides Engages CRO for Phase II Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2506384376","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506384376?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:30","pubTimestamp":1737977400,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc.   today announced that it has engaged a Clinical Research Organization  to conduct a Phase II clinical trial advancing its broad-spectrum antiviral drug NV-387 further into the regulatory pipeline.\"NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in treatment of viral diseases, just as antibiotics revolutionized the treatment of bacterial diseases,\" said Anil R. Diwan, Ph.D., further commenting, \"Our regulatory development strategy for this drug is now further advancing into a Phase II clinical trial stage.\". The Company has previously stated that it is working towards a Phase II clinical trial to evaluate the effectiveness of NV-387 for the treatment of MPox patients. MPox disease, caused by the human Mpox virus  has been causing a regional pandemic encompassing several countries in the African region, including the Democratic Republic of Congo , Uganda, and others. It led to the WHO declar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-engages-cro-phase-ii-113000925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","NNVC","BK4568"],"gpt_icon":0},{"id":"2503303375","title":"NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503303375","media":"ACCESSWIRE","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503303375?lang=en_us&edition=fundamental","pubTime":"2025-01-13 19:30","pubTimestamp":1736767800,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc.  , a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that it is presenting at Biotech Showcase 2025 in San Fransisco, being held in parallel to the JP Morgan Life Sciences Conference.The Phase II-ready drug NV-387 has demonstrated extremely broad antiviral spectrum of activity in animal models, which could prove to be as revolutionary for viral infections as penicillin was for bacterial infections. This broad spectrum is because NV-387 is designed to mimic a host-side feature that is used by over 90-95% of human pathogenic viruses when they cause infection.NV-387 has also shown strong activity in lethal animal model studies for MPox and Smallpox treatment developments. There is no drug for the treatment of MPox infection at present. MPox Clade 1 and 1b infections have caused a continuing pandemic in the Africa that led to WHO declaring a Public H","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-present-biotech-showcase-san-113000907.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","BK4139","NNVC"],"gpt_icon":0},{"id":"2501728483","title":"Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals","url":"https://stock-news.laohu8.com/highlight/detail?id=2501728483","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501728483?lang=en_us&edition=fundamental","pubTime":"2025-01-08 19:30","pubTimestamp":1736335800,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc.  , comments on the many viruses that could cause pandemics that are going around already.This season, two different genotypes of H5N1 bird flu, namely  the severe and lethal form D1.1 that has spread globally in birds, and  the less severe B3.13 genotype widely spread in diary cattle in North America are causing major concerns even as Seasonal Influenza cases abound.In addition to that, in the USA, and globally, there are significant numbers of cases of COVID-19, RSV, and hMPV as expected seasonally, that cause various respiratory syndromes from common colds to bronchitis to pneumonia. Norovirus, a primarily gastro-enteric infection that causes vomiting and severe diarrhea has surged up as well.All of these are RNA viruses that evolve rapidly in the field. All of these can develop resistance to vaccines, antibodies, and existing small chemical drugs  soon after they face such countermeasures i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/multiple-viral-threats-amplify-call-113000300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","NNVC","LU2065732104.USD","SPB","BK4139","BK4548","BK4018","BK4551","BK4568","BNTX","BK4585","BK4535"],"gpt_icon":0},{"id":"2493751950","title":"NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape","url":"https://stock-news.laohu8.com/highlight/detail?id=2493751950","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493751950?lang=en_us&edition=fundamental","pubTime":"2024-12-23 19:30","pubTimestamp":1734953400,"startTime":"0","endTime":"0","summary":"SHELTON, CT / ACCESSWIRE / December 23, 2024 / NanoViricides, Inc.  , says that its broad-spectrum antiviral drug candidate NV-387 is the best weapon to fight a potential bird flu pandemic because the mercurial H5N1 Influenza A virus would not be able to escape the drug.\"Despite all changes, the H5N1 Influenza A virus should remain susceptible to NV-387 because NV-387 mimics the very essential host-side feature that H5N1 continues to use even as it changes,\" said Anil R. Diwan, Ph.D., President and Executive Chairman of the Company, adding \"This drug puts us in a great position to be able to fight a bird flu pandemic should it happen.\". WHO has stated \"Available virus sequences from human cases [of H5 infection] have shown some genetic markers that may reduce susceptibility to neuraminidase inhibitors  [NAIs] or endonuclease inhibitors  [PBIs]\" in their updated public health assessment of recent Influenza A H5 infections, dated December 20, 2024[1].What is more, NV-387 has demonstrated","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nanoviricides-great-position-fight-potential-113000379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4558","NNVC","LU2098885051.SGD","B","BK4588","BK4581","BK4561","BK4585","BK4533","BK4139","BLIV","BK4568","LU0786609619.USD","BK4566","BK4534","BK4146","LU1303367103.USD","LU0823411888.USD","BK4161"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NNVC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"NNVC","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-02-14","symbol":"NNVC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739509200000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2024-11-14","symbol":"NNVC","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2024-09-27","symbol":"NNVC","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1727409600000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2024-05-14","symbol":"NNVC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NNVC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NNVC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NNVC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NNVC","date":"2025-06-04","current":-2.363832,"percent":0.557202,"low":-8.291307,"twenty":-3.802078,"median":-2.494576,"eighty":-2.021017,"high":-1.333135,"avg":-2.972455,"sd":1.394766,"marketCap":22993168},"quantilePoints":[{"date":"2020-06-05","current":-7.433186,"twenty":-11.733077,"median":-6.898164,"eighty":-2.576332,"marketCap":58280963},{"date":"2020-06-12","current":-7.989805,"twenty":-11.691331,"median":-6.898164,"eighty":-2.576332,"marketCap":62645216},{"date":"2020-06-19","current":-7.653514,"twenty":-11.621323,"median":-6.898164,"eighty":-2.576332,"marketCap":60008480},{"date":"2020-06-26","current":-5.26577,"twenty":-11.551315,"median":-6.837974,"eighty":-2.576332,"marketCap":72584000},{"date":"2020-07-02","current":-4.772104,"twenty":-11.551315,"median":-6.780609,"eighty":-2.576332,"marketCap":65779250},{"date":"2020-07-10","current":-5.742813,"twenty":-11.551315,"median":-6.723707,"eighty":-2.576332,"marketCap":79159607},{"date":"2020-07-17","current":-5.361386,"twenty":-11.551315,"median":-6.669738,"eighty":-2.576332,"marketCap":73901971},{"date":"2020-07-24","current":-4.928766,"twenty":-11.551315,"median":-6.613011,"eighty":-2.576332,"marketCap":67938699},{"date":"2020-07-31","current":-4.820612,"twenty":-11.551315,"median":-6.52606,"eighty":-2.576332,"marketCap":66447881},{"date":"2020-08-07","current":-4.897865,"twenty":-11.551315,"median":-6.500126,"eighty":-2.576332,"marketCap":67512751},{"date":"2020-08-14","current":-4.434345,"twenty":-11.551315,"median":-6.462701,"eighty":-2.576332,"marketCap":61123532},{"date":"2020-08-21","current":-3.74679,"twenty":-11.551315,"median":-6.417575,"eighty":-2.576332,"marketCap":51646190},{"date":"2020-08-28","current":-3.167389,"twenty":-11.551315,"median":-6.399341,"eighty":-2.576332,"marketCap":43659665},{"date":"2020-09-04","current":-3.314171,"twenty":-11.551315,"median":-6.344807,"eighty":-2.576332,"marketCap":45682918},{"date":"2020-09-11","current":-3.059234,"twenty":-11.551315,"median":-6.317369,"eighty":-2.576332,"marketCap":42168848},{"date":"2020-09-18","current":-3.329621,"twenty":-11.551315,"median":-6.266676,"eighty":-2.576332,"marketCap":45895892},{"date":"2020-09-25","current":-2.95108,"twenty":-11.551315,"median":-6.134843,"eighty":-2.576332,"marketCap":40678030},{"date":"2020-10-02","current":-2.958805,"twenty":-11.551315,"median":-6.079026,"eighty":-2.576332,"marketCap":40784517},{"date":"2020-10-09","current":-3.151938,"twenty":-11.551315,"median":-5.961802,"eighty":-2.576332,"marketCap":43446691},{"date":"2020-10-16","current":-3.10436,"twenty":-11.551315,"median":-5.869747,"eighty":-2.576332,"marketCap":41742900},{"date":"2020-10-23","current":-3.088522,"twenty":-11.551315,"median":-5.80821,"eighty":-2.576332,"marketCap":41529926},{"date":"2020-10-30","current":-2.731323,"twenty":-11.551315,"median":-5.763677,"eighty":-2.576332,"marketCap":36726837},{"date":"2020-11-06","current":-2.73924,"twenty":-11.551315,"median":-5.704394,"eighty":-2.576332,"marketCap":36833291},{"date":"2020-11-13","current":-2.778824,"twenty":-11.551315,"median":-5.646071,"eighty":-2.576332,"marketCap":37365564},{"date":"2020-11-20","current":-2.817128,"twenty":-11.551315,"median":-5.55316,"eighty":-2.576332,"marketCap":39993750},{"date":"2020-11-27","current":-2.704443,"twenty":-11.551315,"median":-5.550142,"eighty":-2.576332,"marketCap":38394000},{"date":"2020-12-04","current":-2.907276,"twenty":-11.551315,"median":-5.479283,"eighty":-2.576332,"marketCap":41273550},{"date":"2020-12-11","current":-2.606783,"twenty":-11.551315,"median":-5.436362,"eighty":-2.576332,"marketCap":37007550},{"date":"2020-12-18","current":-2.636832,"twenty":-11.551315,"median":-5.410581,"eighty":-2.576332,"marketCap":37434150},{"date":"2020-12-24","current":-2.636832,"twenty":-11.551315,"median":-5.369111,"eighty":-2.576332,"marketCap":37434150},{"date":"2020-12-31","current":-2.156042,"twenty":-11.481307,"median":-5.329042,"eighty":-2.551389,"marketCap":30608550},{"date":"2021-01-08","current":-2.464048,"twenty":-11.481307,"median":-5.269538,"eighty":-2.537233,"marketCap":34981200},{"date":"2021-01-15","current":-2.464048,"twenty":-11.481307,"median":-5.232807,"eighty":-2.519791,"marketCap":34981200},{"date":"2021-01-22","current":-3.327968,"twenty":-11.481307,"median":-5.222018,"eighty":-2.519791,"marketCap":47245950},{"date":"2021-01-29","current":-3.034986,"twenty":-11.481307,"median":-5.155523,"eighty":-2.519791,"marketCap":43086600},{"date":"2021-02-05","current":-3.538313,"twenty":-11.4113,"median":-5.109511,"eighty":-2.519791,"marketCap":50232150},{"date":"2021-02-12","current":-3.78622,"twenty":-11.341292,"median":-5.07155,"eighty":-2.519791,"marketCap":53751600},{"date":"2021-02-19","current":-3.620149,"twenty":-11.311529,"median":-5.024525,"eighty":-2.519791,"marketCap":52851150},{"date":"2021-02-26","current":-3.057014,"twenty":-11.271284,"median":-5.00388,"eighty":-2.519791,"marketCap":44629860},{"date":"2021-03-05","current":-3.876119,"twenty":-11.177066,"median":-4.973773,"eighty":-2.518657,"marketCap":56588100},{"date":"2021-03-12","current":-3.817611,"twenty":-11.075262,"median":-4.952574,"eighty":-2.518657,"marketCap":55733940},{"date":"2021-03-19","current":-3.678656,"twenty":-10.947439,"median":-4.928766,"eighty":-2.518657,"marketCap":53705310},{"date":"2021-03-26","current":-3.605522,"twenty":-10.921244,"median":-4.89353,"eighty":-2.519791,"marketCap":52637610},{"date":"2021-04-01","current":-3.47388,"twenty":-10.851236,"median":-4.872521,"eighty":-2.519791,"marketCap":50715750},{"date":"2021-04-09","current":-3.408059,"twenty":-10.781228,"median":-4.831249,"eighty":-2.518657,"marketCap":49754820},{"date":"2021-04-16","current":-3.00582,"twenty":-10.596948,"median":-4.785979,"eighty":-2.518657,"marketCap":43882470},{"date":"2021-04-23","current":-3.057014,"twenty":-10.508695,"median":-4.726099,"eighty":-2.518657,"marketCap":44629860},{"date":"2021-04-30","current":-3.035074,"twenty":-10.404778,"median":-4.666105,"eighty":-2.518657,"marketCap":44309550},{"date":"2021-05-07","current":-2.654776,"twenty":-9.700722,"median":-4.544321,"eighty":-2.518657,"marketCap":38757510},{"date":"2021-05-14","current":-4.562569,"twenty":-9.419194,"median":-4.510132,"eighty":-2.506117,"marketCap":39347100},{"date":"2021-05-21","current":-4.776022,"twenty":-9.231528,"median":-4.510132,"eighty":-2.506117,"marketCap":41187900},{"date":"2021-05-28","current":-4.789363,"twenty":-9.074029,"median":-4.510132,"eighty":-2.506117,"marketCap":41302950},{"date":"2021-06-04","current":-5.002817,"twenty":-9.026854,"median":-4.518582,"eighty":-2.509122,"marketCap":43143750},{"date":"2021-06-11","current":-5.883312,"twenty":-8.963729,"median":-4.518582,"eighty":-2.509122,"marketCap":50737050},{"date":"2021-06-18","current":-5.082862,"twenty":-8.899973,"median":-4.518582,"eighty":-2.509122,"marketCap":43834050},{"date":"2021-06-25","current":-6.216833,"twenty":-8.83748,"median":-4.518582,"eighty":-2.509122,"marketCap":53613300},{"date":"2021-07-02","current":-5.736563,"twenty":-8.774355,"median":-4.518582,"eighty":-2.509122,"marketCap":49471500},{"date":"2021-07-09","current":-5.576473,"twenty":-8.71123,"median":-4.518582,"eighty":-2.509122,"marketCap":48090900},{"date":"2021-07-16","current":-5.242952,"twenty":-8.71123,"median":-4.518582,"eighty":-2.509122,"marketCap":45214650},{"date":"2021-07-23","current":-5.656518,"twenty":-8.672078,"median":-4.518582,"eighty":-2.509122,"marketCap":48781200},{"date":"2021-07-30","current":-5.363019,"twenty":-8.648105,"median":-4.518582,"eighty":-2.509122,"marketCap":46250100},{"date":"2021-08-06","current":-5.21627,"twenty":-8.605807,"median":-4.518582,"eighty":-2.509122,"marketCap":44984550},{"date":"2021-08-13","current":-5.069521,"twenty":-8.58498,"median":-4.518582,"eighty":-2.509122,"marketCap":43719000},{"date":"2021-08-20","current":-4.949453,"twenty":-8.521855,"median":-4.518582,"eighty":-2.509122,"marketCap":42683550},{"date":"2021-08-27","current":-5.136225,"twenty":-8.381184,"median":-4.527033,"eighty":-2.509122,"marketCap":44294250},{"date":"2021-09-03","current":-5.363019,"twenty":-8.332481,"median":-4.527335,"eighty":-2.509122,"marketCap":46250100},{"date":"2021-09-10","current":-5.256293,"twenty":-8.269356,"median":-4.527335,"eighty":-2.509122,"marketCap":45329700},{"date":"2021-09-17","current":-5.363019,"twenty":-8.206231,"median":-4.527335,"eighty":-2.509122,"marketCap":46250100},{"date":"2021-09-24","current":-6.777149,"twenty":-8.180981,"median":-4.527335,"eighty":-2.509122,"marketCap":58445400},{"date":"2021-10-01","current":-5.869971,"twenty":-8.079981,"median":-4.527335,"eighty":-2.509122,"marketCap":50622000},{"date":"2021-10-08","current":-5.829949,"twenty":-8.016857,"median":-4.527335,"eighty":-2.509122,"marketCap":50276850},{"date":"2021-10-15","current":-6.36953,"twenty":-8.010675,"median":-4.527335,"eighty":-2.509122,"marketCap":56193200},{"date":"2021-10-22","current":-6.304269,"twenty":-7.953732,"median":-4.527335,"eighty":-2.509122,"marketCap":55617450},{"date":"2021-10-29","current":-6.186798,"twenty":-7.94329,"median":-4.527335,"eighty":-2.509122,"marketCap":54581100},{"date":"2021-11-05","current":-6.173746,"twenty":-7.890607,"median":-4.527335,"eighty":-2.509122,"marketCap":54465950},{"date":"2021-11-12","current":-6.095432,"twenty":-7.788302,"median":-4.527335,"eighty":-2.509122,"marketCap":53775050},{"date":"2021-11-19","current":-5.797853,"twenty":-7.663997,"median":-4.527335,"eighty":-2.509122,"marketCap":52899750},{"date":"2021-11-26","current":-6.138903,"twenty":-7.585674,"median":-4.527335,"eighty":-2.509122,"marketCap":56011500},{"date":"2021-12-03","current":-5.633644,"twenty":-7.428051,"median":-4.527335,"eighty":-2.509122,"marketCap":51401500},{"date":"2021-12-10","current":-5.406277,"twenty":-7.300703,"median":-4.527335,"eighty":-2.509122,"marketCap":49327000},{"date":"2021-12-17","current":-5.229436,"twenty":-7.180968,"median":-4.527335,"eighty":-2.509122,"marketCap":47713500},{"date":"2021-12-23","current":-4.976806,"twenty":-7.079181,"median":-4.527335,"eighty":-2.509122,"marketCap":45408500},{"date":"2021-12-31","current":-4.698914,"twenty":-6.987904,"median":-4.527335,"eighty":-2.509122,"marketCap":42873000},{"date":"2022-01-07","current":-3.890498,"twenty":-6.926651,"median":-4.436412,"eighty":-2.509122,"marketCap":35497000},{"date":"2022-01-14","current":-3.675763,"twenty":-6.89782,"median":-4.401483,"eighty":-2.509122,"marketCap":33537750},{"date":"2022-01-21","current":-2.905242,"twenty":-6.846702,"median":-4.310739,"eighty":-2.509122,"marketCap":26507500},{"date":"2022-01-28","current":-2.728401,"twenty":-6.779582,"median":-4.173405,"eighty":-2.509122,"marketCap":24894000},{"date":"2022-02-04","current":-3.05682,"twenty":-6.712109,"median":-4.02803,"eighty":-2.509122,"marketCap":27890500},{"date":"2022-02-11","current":-2.854716,"twenty":-6.637806,"median":-3.995999,"eighty":-2.509122,"marketCap":26046500},{"date":"2022-02-18","current":-2.62043,"twenty":-6.580578,"median":-3.946834,"eighty":-2.509122,"marketCap":22837320},{"date":"2022-02-25","current":-2.646899,"twenty":-6.52606,"median":-3.923893,"eighty":-2.509122,"marketCap":23068000},{"date":"2022-03-04","current":-2.50132,"twenty":-6.496806,"median":-3.868397,"eighty":-2.507562,"marketCap":21799260},{"date":"2022-03-11","current":-2.448382,"twenty":-6.462701,"median":-3.821268,"eighty":-2.492597,"marketCap":21337900},{"date":"2022-03-18","current":-2.964527,"twenty":-6.435992,"median":-3.787617,"eighty":-2.484025,"marketCap":25836160},{"date":"2022-03-25","current":-3.096872,"twenty":-6.399341,"median":-3.766488,"eighty":-2.484025,"marketCap":26989560},{"date":"2022-04-01","current":-2.73954,"twenty":-6.395635,"median":-3.735019,"eighty":-2.484025,"marketCap":23875380},{"date":"2022-04-08","current":-2.593961,"twenty":-6.356646,"median":-3.703835,"eighty":-2.484025,"marketCap":22606640},{"date":"2022-04-14","current":-2.501584,"twenty":-6.335311,"median":-3.656716,"eighty":-2.482663,"marketCap":21801566},{"date":"2022-04-22","current":-2.223395,"twenty":-6.304269,"median":-3.638432,"eighty":-2.478152,"marketCap":19377120},{"date":"2022-04-29","current":-1.97194,"twenty":-6.279718,"median":-3.579246,"eighty":-2.47116,"marketCap":17185660},{"date":"2022-05-06","current":-1.97194,"twenty":-6.219501,"median":-3.523708,"eighty":-2.460477,"marketCap":17185660},{"date":"2022-05-13","current":-1.710426,"twenty":-6.176384,"median":-3.477537,"eighty":-2.45259,"marketCap":14906541},{"date":"2022-05-20","current":-3.57635,"twenty":-6.112925,"median":-3.448283,"eighty":-2.44683,"marketCap":30040400},{"date":"2022-05-27","current":-2.957366,"twenty":-6.0948,"median":-3.404402,"eighty":-2.44683,"marketCap":24841100},{"date":"2022-06-03","current":-2.751038,"twenty":-6.063146,"median":-3.382022,"eighty":-2.44683,"marketCap":23108000},{"date":"2022-06-10","current":-2.778549,"twenty":-6.021887,"median":-3.36235,"eighty":-2.44683,"marketCap":23339080},{"date":"2022-06-17","current":-2.764793,"twenty":-5.978029,"median":-3.327968,"eighty":-2.44683,"marketCap":23223540},{"date":"2022-06-24","current":-2.806059,"twenty":-5.953332,"median":-3.30945,"eighty":-2.445278,"marketCap":23570160},{"date":"2022-07-01","current":-2.599731,"twenty":-5.898451,"median":-3.23985,"eighty":-2.445278,"marketCap":21837060},{"date":"2022-07-08","current":-3.148563,"twenty":-5.871439,"median":-3.219656,"eighty":-2.445278,"marketCap":26447106},{"date":"2022-07-15","current":-2.737283,"twenty":-5.837732,"median":-3.192745,"eighty":-2.445278,"marketCap":22992460},{"date":"2022-07-22","current":-2.874835,"twenty":-5.807263,"median":-3.167389,"eighty":-2.445278,"marketCap":24147860},{"date":"2022-07-29","current":-2.503445,"twenty":-5.78537,"median":-3.144776,"eighty":-2.440257,"marketCap":21028280},{"date":"2022-08-05","current":-4.869338,"twenty":-5.744619,"median":-3.132647,"eighty":-2.440257,"marketCap":40901160},{"date":"2022-08-12","current":-3.823943,"twenty":-5.727928,"median":-3.132647,"eighty":-2.440257,"marketCap":32120120},{"date":"2022-08-19","current":-3.342511,"twenty":-5.684312,"median":-3.132647,"eighty":-2.440257,"marketCap":28076220},{"date":"2022-08-26","current":-3.094918,"twenty":-5.661854,"median":-3.132245,"eighty":-2.440257,"marketCap":25996500},{"date":"2022-09-02","current":-2.902345,"twenty":-5.581809,"median":-3.128118,"eighty":-2.440257,"marketCap":24378940},{"date":"2022-09-09","current":-2.984876,"twenty":-5.560806,"median":-3.117013,"eighty":-2.440257,"marketCap":25072180},{"date":"2022-09-16","current":-2.668507,"twenty":-5.55316,"median":-3.10436,"eighty":-2.440257,"marketCap":22414760},{"date":"2022-09-23","current":-2.14581,"twenty":-5.519162,"median":-3.095823,"eighty":-2.439684,"marketCap":18024240},{"date":"2022-09-30","current":-2.379648,"twenty":-5.477266,"median":-3.088522,"eighty":-2.439647,"marketCap":19988420},{"date":"2022-10-07","current":-2.132055,"twenty":-5.456405,"median":-3.080603,"eighty":-2.439647,"marketCap":17908700},{"date":"2022-10-14","current":-2.502362,"twenty":-5.43594,"median":-3.072683,"eighty":-2.437394,"marketCap":20286302},{"date":"2022-10-21","current":-2.402267,"twenty":-5.421719,"median":-3.06696,"eighty":-2.434784,"marketCap":19474850},{"date":"2022-10-28","current":-2.359369,"twenty":-5.377446,"median":-3.06013,"eighty":-2.430342,"marketCap":19127085},{"date":"2022-11-04","current":-2.334363,"twenty":-5.363019,"median":-3.057014,"eighty":-2.4206,"marketCap":18924360},{"date":"2022-11-11","current":-2.477575,"twenty":-5.336338,"median":-3.043934,"eighty":-2.417533,"marketCap":20085364},{"date":"2022-11-18","current":-2.711681,"twenty":-5.332826,"median":-3.036058,"eighty":-2.417533,"marketCap":19156500},{"date":"2022-11-25","current":-2.760984,"twenty":-5.332826,"median":-3.034986,"eighty":-2.417533,"marketCap":19504800},{"date":"2022-12-02","current":-2.777419,"twenty":-5.332826,"median":-3.028333,"eighty":-2.417533,"marketCap":19620900},{"date":"2022-12-09","current":-2.39121,"twenty":-5.292381,"median":-3.026142,"eighty":-2.416192,"marketCap":16892550},{"date":"2022-12-16","current":-2.087173,"twenty":-5.292381,"median":-3.018926,"eighty":-2.406742,"marketCap":14744700},{"date":"2022-12-23","current":-1.972132,"twenty":-5.292381,"median":-3.00582,"eighty":-2.395506,"marketCap":13932000},{"date":"2022-12-30","current":-1.824222,"twenty":-5.292381,"median":-2.997432,"eighty":-2.389879,"marketCap":12887100},{"date":"2023-01-06","current":-2.202214,"twenty":-5.277173,"median":-2.989706,"eighty":-2.387968,"marketCap":15557400},{"date":"2023-01-13","current":-2.333853,"twenty":-5.260084,"median":-2.981981,"eighty":-2.376115,"marketCap":16487361},{"date":"2023-01-20","current":-2.30082,"twenty":-5.250996,"median":-2.973783,"eighty":-2.373517,"marketCap":16254000},{"date":"2023-01-27","current":-2.399427,"twenty":-5.240028,"median":-2.96653,"eighty":-2.370947,"marketCap":16950600},{"date":"2023-02-03","current":-2.284386,"twenty":-5.221675,"median":-2.956693,"eighty":-2.366583,"marketCap":16137900},{"date":"2023-02-10","current":-2.276169,"twenty":-5.202929,"median":-2.950137,"eighty":-2.360695,"marketCap":16079850},{"date":"2023-02-17","current":-2.44914,"twenty":-5.171998,"median":-2.943354,"eighty":-2.359369,"marketCap":16870750},{"date":"2023-02-24","current":-2.128219,"twenty":-5.154465,"median":-2.937326,"eighty":-2.348627,"marketCap":14660100},{"date":"2023-03-03","current":-2.330906,"twenty":-5.122989,"median":-2.92765,"eighty":-2.343232,"marketCap":16056300},{"date":"2023-03-10","current":-2.145109,"twenty":-5.087088,"median":-2.913716,"eighty":-2.342061,"marketCap":14776450},{"date":"2023-03-17","current":-2.195781,"twenty":-5.05618,"median":-2.905242,"eighty":-2.334159,"marketCap":15125500},{"date":"2023-03-24","current":-2.094437,"twenty":-5.017952,"median":-2.902345,"eighty":-2.329408,"marketCap":14427400},{"date":"2023-03-31","current":-1.97975,"twenty":-5.017055,"median":-2.891819,"eighty":-2.325041,"marketCap":13637383},{"date":"2023-04-06","current":-2.753172,"twenty":-5.017055,"median":-2.888698,"eighty":-2.322276,"marketCap":18965050},{"date":"2023-04-14","current":-1.993094,"twenty":-5.017952,"median":-2.874835,"eighty":-2.316037,"marketCap":13729300},{"date":"2023-04-21","current":-2.263344,"twenty":-5.002368,"median":-2.859591,"eighty":-2.313801,"marketCap":15590900},{"date":"2023-04-28","current":-2.280234,"twenty":-5.002368,"median":-2.849614,"eighty":-2.312786,"marketCap":15707250},{"date":"2023-05-05","current":-2.077547,"twenty":-5.002368,"median":-2.840873,"eighty":-2.302937,"marketCap":14311050},{"date":"2023-05-11","current":-2.043766,"twenty":-5.002368,"median":-2.835777,"eighty":-2.30082,"marketCap":14078350},{"date":"2023-05-19","current":-1.920317,"twenty":-5.002518,"median":-2.832097,"eighty":-2.294808,"marketCap":13055420},{"date":"2023-05-26","current":-1.887542,"twenty":-5.002667,"median":-2.817128,"eighty":-2.284962,"marketCap":12832600},{"date":"2023-06-02","current":-2.239311,"twenty":-5.002667,"median":-2.810544,"eighty":-2.283362,"marketCap":15224130},{"date":"2023-06-09","current":-1.973339,"twenty":-5.002817,"median":-2.806059,"eighty":-2.276679,"marketCap":13415900},{"date":"2023-06-16","current":-1.870383,"twenty":-5.008153,"median":-2.792391,"eighty":-2.269675,"marketCap":12715940},{"date":"2023-06-23","current":-1.921861,"twenty":-5.010821,"median":-2.779567,"eighty":-2.263344,"marketCap":13065920},{"date":"2023-06-30","current":-2.144934,"twenty":-5.017055,"median":-2.778549,"eighty":-2.263295,"marketCap":14582500},{"date":"2023-07-06","current":-2.024818,"twenty":-5.017952,"median":-2.777419,"eighty":-2.259272,"marketCap":13765880},{"date":"2023-07-14","current":-2.488124,"twenty":-5.020645,"median":-2.769833,"eighty":-2.254292,"marketCap":16915700},{"date":"2023-07-21","current":-2.745516,"twenty":-5.0361,"median":-2.767019,"eighty":-2.252684,"marketCap":18665600},{"date":"2023-07-27","current":-2.676878,"twenty":-5.039964,"median":-2.764793,"eighty":-2.252282,"marketCap":18198960},{"date":"2023-08-04","current":-2.453805,"twenty":-5.039964,"median":-2.753964,"eighty":-2.252129,"marketCap":16682380},{"date":"2023-08-11","current":-2.219738,"twenty":-5.039964,"median":-2.751307,"eighty":-2.246058,"marketCap":15091061},{"date":"2023-08-18","current":-2.21991,"twenty":-5.039964,"median":-2.751307,"eighty":-2.244476,"marketCap":15092230},{"date":"2023-08-25","current":-2.667127,"twenty":-5.039964,"median":-2.753168,"eighty":-2.251186,"marketCap":18132670},{"date":"2023-09-01","current":-2.495054,"twenty":-5.039964,"median":-2.751038,"eighty":-2.251186,"marketCap":16962820},{"date":"2023-09-08","current":-2.340189,"twenty":-5.039964,"median":-2.74376,"eighty":-2.251186,"marketCap":15909955},{"date":"2023-09-15","current":-2.288567,"twenty":-5.039964,"median":-2.738088,"eighty":-2.246453,"marketCap":15559001},{"date":"2023-09-22","current":-2.185324,"twenty":-5.039964,"median":-2.725967,"eighty":-2.236945,"marketCap":14857091},{"date":"2023-09-29","current":-2.426225,"twenty":-5.039964,"median":-2.723609,"eighty":-2.236573,"marketCap":16494880},{"date":"2023-10-06","current":-2.254153,"twenty":-5.039964,"median":-2.723609,"eighty":-2.234464,"marketCap":15325031},{"date":"2023-10-13","current":-2.013251,"twenty":-5.039964,"median":-2.723467,"eighty":-2.230216,"marketCap":13687241},{"date":"2023-10-20","current":-1.572776,"twenty":-5.039964,"median":-2.723467,"eighty":-2.222732,"marketCap":13507900},{"date":"2023-10-27","current":-1.600128,"twenty":-5.039964,"median":-2.72369,"eighty":-2.219772,"marketCap":13742820},{"date":"2023-11-03","current":-1.5591,"twenty":-5.039964,"median":-2.72369,"eighty":-2.211571,"marketCap":13390440},{"date":"2023-11-10","current":-1.463365,"twenty":-5.039964,"median":-2.718749,"eighty":-2.202243,"marketCap":12568220},{"date":"2023-11-17","current":-1.487026,"twenty":-5.039964,"median":-2.715489,"eighty":-2.195907,"marketCap":13363424},{"date":"2023-11-24","current":-1.359275,"twenty":-5.039964,"median":-2.713071,"eighty":-2.189723,"marketCap":12215368},{"date":"2023-12-01","current":-1.503045,"twenty":-5.039964,"median":-2.709773,"eighty":-2.185324,"marketCap":13507379},{"date":"2023-12-08","current":-1.50958,"twenty":-5.039964,"median":-2.70214,"eighty":-2.168223,"marketCap":13566106},{"date":"2023-12-15","current":-1.489975,"twenty":-5.039964,"median":-2.696474,"eighty":-2.162,"marketCap":13389923},{"date":"2023-12-22","current":-1.385415,"twenty":-5.039964,"median":-2.696474,"eighty":-2.156514,"marketCap":12450279},{"date":"2023-12-29","current":-1.398485,"twenty":-5.039964,"median":-2.696931,"eighty":-2.156278,"marketCap":12567735},{"date":"2024-01-05","current":-1.424625,"twenty":-5.039964,"median":-2.698293,"eighty":-2.150909,"marketCap":12802646},{"date":"2024-01-12","current":-1.353525,"twenty":-5.039964,"median":-2.698293,"eighty":-2.145109,"marketCap":12163688},{"date":"2024-01-19","current":-1.359275,"twenty":-5.043083,"median":-2.699655,"eighty":-2.135592,"marketCap":12215368},{"date":"2024-01-26","current":-1.385415,"twenty":-5.039964,"median":-2.698293,"eighty":-2.120042,"marketCap":12450279},{"date":"2024-02-02","current":-1.476905,"twenty":-5.039964,"median":-2.698293,"eighty":-2.111328,"marketCap":13272468},{"date":"2024-02-09","current":-1.516115,"twenty":-5.039964,"median":-2.687524,"eighty":-2.094437,"marketCap":13624834},{"date":"2024-02-16","current":-1.498107,"twenty":-5.039964,"median":-2.682084,"eighty":-2.081184,"marketCap":14017010},{"date":"2024-02-23","current":-1.59882,"twenty":-5.039964,"median":-2.676392,"eighty":-2.064581,"marketCap":14959330},{"date":"2024-03-01","current":-1.699533,"twenty":-5.0361,"median":-2.668507,"eighty":-2.049674,"marketCap":15901650},{"date":"2024-03-08","current":-1.422572,"twenty":-5.0361,"median":-2.666881,"eighty":-2.03312,"marketCap":13310270},{"date":"2024-03-15","current":-1.472929,"twenty":-5.0361,"median":-2.656354,"eighty":-2.014962,"marketCap":13781430},{"date":"2024-03-22","current":-1.435162,"twenty":-5.0361,"median":-2.651857,"eighty":-1.997134,"marketCap":13428060},{"date":"2024-03-28","current":-1.422572,"twenty":-5.0361,"median":-2.646899,"eighty":-1.988953,"marketCap":13310270},{"date":"2024-04-05","current":-1.724712,"twenty":-5.039964,"median":-2.645782,"eighty":-1.976203,"marketCap":16137230},{"date":"2024-04-12","current":-1.59882,"twenty":-5.039964,"median":-2.640997,"eighty":-1.967997,"marketCap":14959330},{"date":"2024-04-19","current":-1.479223,"twenty":-5.039964,"median":-2.636576,"eighty":-1.942422,"marketCap":13840325},{"date":"2024-04-26","current":-1.397394,"twenty":-5.0361,"median":-2.625126,"eighty":-1.921861,"marketCap":13074690},{"date":"2024-05-03","current":-1.510696,"twenty":-5.0361,"median":-2.62043,"eighty":-1.908491,"marketCap":14134800},{"date":"2024-05-10","current":-2.303812,"twenty":-5.0361,"median":-2.62043,"eighty":-1.904702,"marketCap":21555570},{"date":"2024-05-17","current":-2.762595,"twenty":-5.0361,"median":-2.63632,"eighty":-1.904702,"marketCap":26267170},{"date":"2024-05-24","current":-2.762595,"twenty":-5.0361,"median":-2.640997,"eighty":-1.904702,"marketCap":26267170},{"date":"2024-05-31","current":-3.010361,"twenty":-5.0361,"median":-2.645943,"eighty":-1.904702,"marketCap":28622970},{"date":"2024-06-07","current":-3.282904,"twenty":-5.0361,"median":-2.651857,"eighty":-1.904702,"marketCap":31214350},{"date":"2024-06-14","current":-3.205683,"twenty":-5.039964,"median":-2.663299,"eighty":-1.904702,"marketCap":30480120},{"date":"2024-06-21","current":-2.522301,"twenty":-5.039964,"median":-2.666881,"eighty":-1.904582,"marketCap":23982420},{"date":"2024-06-28","current":-2.149547,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20438220},{"date":"2024-07-05","current":-2.186822,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20792640},{"date":"2024-07-12","current":-2.236523,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":21265200},{"date":"2024-07-15","current":-2.161972,"twenty":-5.039964,"median":-2.667004,"eighty":-1.904221,"marketCap":20556360},{"date":"2024-08-02","current":-2.609277,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":24809400},{"date":"2024-08-09","current":-2.360774,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":22446600},{"date":"2024-08-16","current":-2.360774,"twenty":-5.05618,"median":-2.674394,"eighty":-1.887542,"marketCap":22446600},{"date":"2024-08-23","current":-2.286223,"twenty":-5.05618,"median":-2.675731,"eighty":-1.887542,"marketCap":21737760},{"date":"2024-08-30","current":-2.335924,"twenty":-5.05618,"median":-2.675731,"eighty":-1.890067,"marketCap":22210320},{"date":"2024-09-06","current":-2.224098,"twenty":-5.05618,"median":-2.675731,"eighty":-1.890067,"marketCap":21147060},{"date":"2024-09-13","current":-2.087421,"twenty":-5.05618,"median":-2.675731,"eighty":-1.899521,"marketCap":19847520},{"date":"2024-09-20","current":-1.96317,"twenty":-5.05618,"median":-2.675731,"eighty":-1.917578,"marketCap":18666120},{"date":"2024-09-27","current":-1.764368,"twenty":-5.05618,"median":-2.675731,"eighty":-1.921243,"marketCap":16775880},{"date":"2024-10-04","current":-2.008373,"twenty":-5.05618,"median":-2.675731,"eighty":-1.947416,"marketCap":16657740},{"date":"2024-10-11","current":-1.951398,"twenty":-5.05618,"median":-2.675731,"eighty":-1.961627,"marketCap":16185180},{"date":"2024-10-18","current":-2.122323,"twenty":-5.05618,"median":-2.675731,"eighty":-1.972856,"marketCap":17602860},{"date":"2024-10-25","current":-2.122323,"twenty":-5.05618,"median":-2.675731,"eighty":-1.978331,"marketCap":17602860},{"date":"2024-10-31","current":-1.937154,"twenty":-5.05618,"median":-2.675731,"eighty":-1.988348,"marketCap":16067040},{"date":"2024-11-08","current":-2.122323,"twenty":-5.05618,"median":-2.675818,"eighty":-2.003331,"marketCap":17602860},{"date":"2024-11-15","current":-1.908667,"twenty":-5.05618,"median":-2.675818,"eighty":-2.007658,"marketCap":15830760},{"date":"2024-11-22","current":-1.599829,"twenty":-5.05618,"median":-2.675818,"eighty":-2.007658,"marketCap":15121920},{"date":"2024-11-29","current":-2.06427,"twenty":-5.05618,"median":-2.675818,"eighty":-2.022617,"marketCap":19511920},{"date":"2024-12-06","current":-2.216055,"twenty":-5.05618,"median":-2.675818,"eighty":-2.028308,"marketCap":20946620},{"date":"2024-12-13","current":-2.231234,"twenty":-5.05618,"median":-2.675818,"eighty":-2.043766,"marketCap":21090090},{"date":"2024-12-20","current":-2.200877,"twenty":-5.05618,"median":-2.675818,"eighty":-2.051201,"marketCap":20803150},{"date":"2024-12-27","current":-2.291947,"twenty":-5.05618,"median":-2.675818,"eighty":-2.063251,"marketCap":21663970},{"date":"2025-01-03","current":-2.155341,"twenty":-5.05618,"median":-2.675818,"eighty":-2.067504,"marketCap":20372740},{"date":"2025-01-10","current":-2.109806,"twenty":-5.05618,"median":-2.675905,"eighty":-2.079813,"marketCap":19942330},{"date":"2025-01-17","current":-1.821415,"twenty":-5.05618,"median":-2.675905,"eighty":-2.079813,"marketCap":17216400},{"date":"2025-01-24","current":-1.699987,"twenty":-5.05618,"median":-2.675731,"eighty":-2.077956,"marketCap":16068640},{"date":"2025-01-31","current":-1.624095,"twenty":-5.019747,"median":-2.668507,"eighty":-2.064332,"marketCap":15351290},{"date":"2025-02-07","current":-1.86695,"twenty":-4.974978,"median":-2.666881,"eighty":-2.051347,"marketCap":17646810},{"date":"2025-02-14","current":-1.958021,"twenty":-4.948211,"median":-2.651857,"eighty":-2.049178,"marketCap":18507630},{"date":"2025-02-21","current":-2.42188,"twenty":-4.923399,"median":-2.645943,"eighty":-2.049178,"marketCap":22680335},{"date":"2025-02-28","current":-2.238151,"twenty":-4.869408,"median":-2.636832,"eighty":-2.049178,"marketCap":20959758},{"date":"2025-03-07","current":-2.204746,"twenty":-4.859238,"median":-2.619088,"eighty":-2.043766,"marketCap":20646926},{"date":"2025-03-14","current":-2.021017,"twenty":-4.814317,"median":-2.611175,"eighty":-2.043766,"marketCap":18926349},{"date":"2025-03-21","current":-2.204746,"twenty":-4.762681,"median":-2.603257,"eighty":-2.043766,"marketCap":20646926},{"date":"2025-03-28","current":-2.021017,"twenty":-4.736,"median":-2.593961,"eighty":-2.037721,"marketCap":18926349},{"date":"2025-04-04","current":-1.904099,"twenty":-4.695977,"median":-2.574477,"eighty":-2.024878,"marketCap":17831436},{"date":"2025-04-11","current":-1.78718,"twenty":-4.601221,"median":-2.559576,"eighty":-2.021017,"marketCap":16736523},{"date":"2025-04-17","current":-2.338367,"twenty":-4.561033,"median":-2.554258,"eighty":-2.021017,"marketCap":21898255},{"date":"2025-04-25","current":-2.254854,"twenty":-4.395718,"median":-2.539152,"eighty":-2.021017,"marketCap":21116174},{"date":"2025-05-02","current":-2.221448,"twenty":-4.236599,"median":-2.517715,"eighty":-2.021017,"marketCap":20803342},{"date":"2025-05-09","current":-2.355069,"twenty":-4.022387,"median":-2.509122,"eighty":-2.021017,"marketCap":22054671},{"date":"2025-05-16","current":-2.188043,"twenty":-3.94774,"median":-2.501973,"eighty":-2.021017,"marketCap":20490510},{"date":"2025-05-23","current":-2.379913,"twenty":-3.876119,"median":-2.498632,"eighty":-2.021017,"marketCap":23149584},{"date":"2025-05-30","current":-2.524637,"twenty":-3.823943,"median":-2.498632,"eighty":-2.021017,"marketCap":24557329},{"date":"2025-06-04","current":-2.363832,"twenty":-3.802078,"median":-2.494576,"eighty":-2.021017,"marketCap":22993168}],"updateTime":1749127673268}}}